Caracemide supplier | CasNO.81424-67-1

Name
Caracemide
EINECS
CAS No. 81424-67-1
Density 1.259g/cm³
Solubility
Melting Point 122.25°C
Formula C6H11 N3 O4
Boiling Point 324.41°C (rough estimate)
Molecular Weight 189.171
Flash Point
Transport Information
Appearance
Safety Poison by ingestion, intravenous, and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NO_x.
Risk Codes
Molecular Structure
Hazard Symbols
Synonyms Caracemide;N-Acetyl-N,O-di(methylcarbamoyl)hydroxylamine; NSC 253272
PSA 87.74000
LogP 0.22710

Caracemide Chemical Properties

IUPAC Name: [Acetyl(methylcarbamoyl)amino] N-methylcarbamate
Molecular Formula: C₆H₁₁N₃O₄
Molecular Weight: 189.20g/mol
Density: 1.259 g/cm³
Melting Point: 121–123.5°C
Properties: crystals
Freely Rotating Bonds: 2
Polar Surface Area: 70.16 Å²
Index of Refraction: 1.479
Molar Refractivity: 42.59 cm³
Molar Volume: 150.1 cm³
Polarizability: 16.88× 10^-24 cm³
Surface Tension: 44.2 dyne/cm
The Cas Register Number of Caracemide is 81424-67-1.The chemical synonyms of Caracemide (CAS NO.81424-67-1) are Acetamide, N-((methylamino)carbonyl)-N-(((methylamino)carbonyl)oxy)- ; Acetamide, N-((methylamino)carbonyl)-N-((methylamino)carbonyl)oxy- ; Acetamide, N-[ (methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]- ; Caracemida [Spanish] ; Caracemide (USAN) .The molecular structure of Caracemide (CAS NO.81424-67-1) is .

Caracemide Uses

Caracemide (CAS NO.81424-67-1) is used as pharmaceutical intermediate.

Caracemide Production

It is derived when Acetohydroxamic acid (I) reacts with two moles of methyl isocyanate (II).

Caracemide Toxicity Data With Reference

1.	mmo-sat 5 µmol/plate	MUREAV Mutation Research. 172 (1986),199.
2.	dni-hmn:leu 50 µmol/L	NEOLA4 Neoplasma. 35 (1988),27.
3.	orl-mus LD50:388 mg/kg	NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 .
4.	ipr-mus LD50:167 mg/kg	NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 .
5.	ivn-mus LD50:238 mg/kg	NTIS** National Technical Information Service. (Springfield, VA 22161) (Formerly U.S. Clearinghouse for Scientific and Technical Information) PB84-152032 .

Caracemide Safety Profile

Poison by ingestion, intravenous, and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NO_x.

Caracemide Specification

Its extinguishing agent are water, carbon dioxide, foam and dry powder.

Product Name

Caracemide